Nanotechnology Conference and Trade Show - Nanotech 2006
> Program > Technical Conferences > Business & Development > Nano Impact Workshop > Nanotech Job Fair > Expo
Program
Sessions
Sunday
Monday
Tuesday
Wednesday
Thursday
Index of Authors
Index of Keywords
Confirmed Speakers
Conferences & Symposia

Conference Proceedings

Conference Technical Proceedings

Development of Tumor Targeting Magnetic Nanoparticles for Cancer Therapy

R. Ivkov, S.J. DeNardo, L.A. Miers, A. Natarajan, A.R. Foreman, C. Gruettner, G.N. Adamson and G.L. DeNardo
Triton BioSystems, Inc., US

Keywords:
cancer, immunotherapy, magnetic nanoparticles, antibodies, thermotherapy

Abstract:
111In-ChL6 MAb-linked iron oxide nanoparticles (bioprobes) pharmacokinetics, tumor uptake and the therapeutic effect of inductively heating these bioprobes by an externally applied AMF were studied in athymic mice bearing human breast cancer HBT3477 xenografts. Bioprobe doses (20mg/2.2mg ChL6/ bioprobe), were administered i.v. with 50μg ChL6; a 153 kHz AMF was given 72 hr post injection (pi) for therapy with amplitudes of 1,300, 1,000 or 700 Oersteds. Weights, blood counts and tumor size were monitored and compared with control mice receiving nothing, or AMF or bioprobes alone. 111In-ChL6 bioprobe binding in vitro to HBT3477 cells was 50 to 70% of that of 111In-ChL6. At 48 hours, tumor, lung, kidney, and marrow uptake of the 111In-ChL6 bioprobes were not different from that observed in prior studies of 111In-ChL6. Significant therapeutic responses from AMF/bioprobe therapy were demonstrated. Toxicity was only seen in the 1,300 Oe AMF cohort, with 4 of 12 immediate deaths and skin erythema. Electron micrographs showed bioprobes on the surfaces of the HBT3477 cells of excised tumors and tumor necrosis 24 hours after AMF/bioprobe therapy. This study shows that mAb-conjugated nanoparticles (bioprobes), when given i.v., escape into the extravascular space and bind to cancer cell membrane antigen, so that bioprobes can be used in concert with externally applied AMF to deliver thermoablative cancer therapy.

Back to Program

Sessions Sunday Monday Tuesday Wednesday Thursday Authors

Nanotech 2006 Conference Program Abstract

 
Nanotechnology Conference | Terms of use | Privacy policy | Contact | NSTI Home
Program | Technical Conferences | Business & Development | Nano Impact Workshop | Nanotech Job Fair | Expo |
Nanotech 2006 Home | Press Room | Venue | Subscribe | Site Map
Names, and logos of other organizations are the property of those organizations and not of NSTI.
This event is not open to the general public and NSTI reserves the right to refuse admission and participation to any individual.